02367nam 22005771 450 991082908850332120240314024901.01-60805-747-X(CKB)2670000000402537(EBL)1336319(OCoLC)855504888(SSID)ssj0001127419(PQKBManifestationID)11669035(PQKBTitleCode)TC0001127419(PQKBWorkID)11150175(PQKB)10182177(MiAaPQ)EBC1336319(Au-PeEL)EBL1336319(CaPaEBR)ebr10762668(EXLCZ)99267000000040253720130810d2013 uy 0engur|n|---|||||txtccrErythropoietic stimulating agents /editor, Elisio Costa; co-editors, Flavio Reis and Alice Santos-Silva1st ed.Oak Park, Illinois :Bentham Science Publishers,2013.1 online resource (306 p.)Frontiers in drug discovery ;v. 1Includes index.1-60805-748-8 Cover; TItle; EUL; Contents; Foreword; Preface; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chatper 07; Chapter 08; Chatper 09; Chapter 10; Chapter 11; Chapter 12; Chapter 13; Chapter 14; Index; Bak CoverThis volume includes a revision of articles on erythropoiesis and EPO gene regulation, microRNAs and their potential contribution to the development of new therapeutic strategies, animal models for studying kidney disease-associated anemia as well as benefits/risks of ESA therapy. The biological effects of new ESA molecules, heparin-binding erythropoietin and of pHBSP, and the potential applications of ESA, are also elicited in this volume.Frontiers in Drug DiscoveryErythrocytesErythropoiesisRegulationErythrocytes.ErythropoiesisRegulation.612.111Costa Elisio1604688Reis Flávio1604689Santos-Silva Alice1604690MiAaPQMiAaPQMiAaPQBOOK9910829088503321Erythropoietic stimulating agents3929636UNINA